Surgical Excision of Hand Vascular Tumors: An Intraoperative Masterclass

Introduction and Nomenclature of Vascular Anomalies

Vascular tumors and anomalies of the upper extremity exhibit a profound diversity in clinical presentation, biologic behavior, and histopathology. Historically, the nomenclature surrounding these lesions has been notoriously convoluted. The ambiguity largely stems from the ubiquitous use of the term "tumor," which literally translates to "swelling" but in modern oncologic parlance denotes a proliferative neoplastic process. For decades, vascular lesions were categorized based on rudimentary clinical descriptors (e.g., "strawberry hemangioma," "port-wine stain") rather than precise histopathologic or hemodynamic characteristics. Consequently, the term "hemangioma" was erroneously applied to a vast array of biologically disparate lesions, leading to inappropriate management strategies and unpredictable surgical outcomes.

To rectify this, the International Society for the Study of Vascular Anomalies (ISSVA) adopted a standardized, biologically based classification system in 1996, which has since been universally integrated into orthopedic and vascular surgery. The ISSVA classification fundamentally bifurcates congenital vascular lesions into two distinct categories: Vascular Tumors and Vascular Malformations.

Vascular tumors (e.g., infantile hemangiomas) are true neoplasms defined by endothelial cell hyperplasia and proliferation. Conversely, vascular malformations are nonproliferative, dysmorphic errors of vascular morphogenesis consisting of mature, flat endothelial cells. Approximately 90% of all vascular growths in the hand fall into the category of benign congenital lesions (tumors or malformations). The remaining 10% encompass acquired noncongenital tumors (e.g., glomus tumors), malignant neoplasms (e.g., hemangioendotheliomas, angiosarcomas), and traumatic or iatrogenic lesions (e.g., pseudoaneurysms, acquired arteriovenous fistulas).

The incidence of congenital vascular tumors and malformations in the general population ranges from 2% to 6%. While the majority are identified at birth or during early infancy, deeper or low-flow malformations may remain clinically occult until adolescence or adulthood. Between 15% and 26% of all vascular anomalies manifest in the extremities, with a distinct predilection for the hand and forearm. Within the upper extremity, vascular anomalies represent the fourth most common soft-tissue tumor, superseded only by ganglion cysts, giant cell tumors of the tendon sheath, and epidermal inclusion cysts.

Surgical Anatomy and Pathogenesis

A rigorous understanding of the microvascular anatomy of the hand is prerequisite for the surgical management of these lesions. The arterial architecture of the hand terminates either in standard capillary beds or within specialized arteriovenous shunts known as glomus bodies.

The glomus body functions as a highly specialized neuromyoarterial mechanoreceptor and thermoregulator. Anatomically situated within the stratum reticularis of the dermis, glomus bodies are found in highest concentration within the subungual regions and the volar tactile pads of the digits. Physiologically, the glomus body regulates peripheral blood flow—and consequently peripheral blood pressure and core temperature—by bypassing the capillary bed via narrow, endothelium-lined anastomotic channels called Sucquet-Hoyer canals. These canals are enveloped by specialized smooth muscle cells (glomus cells) and a rich network of nonmyelinated sympathetic nerve fibers.

The pathogenesis of vascular anomalies remains a subject of ongoing investigation, with distinct mechanisms proposed for tumors versus malformations:
* Vascular Tumors: Endothelial proliferation in infantile hemangiomas is hypothesized to originate from either embolized, disrupted placental tissue embedded within fetal soft tissues, or from circulating, aberrant multipotent hematopoietic stem cells that undergo localized clonal expansion.
* Vascular Malformations: These lesions arise from localized arrests or derangements in embryonic vascular development. They represent a failure of differentiation or a failure of involution of primitive embryonic vascular plexuses.
* Acquired Lesions: Acquired vascular masses typically result from mechanical trauma (blunt or penetrating) that disrupts the structural integrity of the vessel wall, leading to the formation of pseudoaneurysms or traumatic arteriovenous fistulas (AVFs).

Classification and Natural History of Vascular Anomalies

Vascular Tumors

Infantile Hemangiomas

Infantile hemangiomas are the most common true vascular tumors. They are characterized by a classic multiphasic life cycle: rapid postnatal proliferation, a plateau phase, and subsequent spontaneous involution. Histologically, they demonstrate robust endothelial proliferation and are uniquely positive for Glucose-1-Transporter (GLUT-1).

Kaposiform Hemangioendothelioma

Historically and erroneously grouped with benign capillary hemangiomas, kaposiform hemangioendotheliomas are rare, locally aggressive tumors. Histopathologically, they are distinguished by tightly packed, "cannonball" nests of spindled endothelial cells within the dermis, bearing a morphologic resemblance to Kaposi sarcoma. Crucially, these lesions do not spontaneously involute. They are frequently associated with the Kasabach-Merritt phenomenon (profound consumptive thrombocytopenia and coagulopathy). Surgical resection or systemic therapy (e.g., vincristine) is mandatory.

Lobular Capillary Hemangiomas (Pyogenic Granulomas)

Representing approximately 20% of vascular tumors in the hand, lobular capillary hemangiomas present as rapidly growing, well-circumscribed, friable, and pedunculated outgrowths. They possess a high propensity for spontaneous or minor trauma-induced hemorrhage. In pediatric populations, they frequently occur on the glabrous skin of the digits and palms, whereas in adults, they often present as an overgrowth of granulation-like tissue following penetrating trauma to the fingers or toes.

Vascular Leiomyomas

Vascular leiomyomas (angioleiomyomas) are benign tumors originating from the tunica media of venous structures. They typically present as slow-growing, painful, well-circumscribed subcutaneous nodules. Intraoperatively, they can be difficult to distinguish from organizing aneurysms prior to histopathologic confirmation.

Vascular Malformations

Vascular malformations are uniformly present at birth, though they may not become clinically apparent until triggered by trauma, hormonal fluctuations (e.g., puberty, pregnancy), infection, or iatrogenic surgical intervention. Unlike hemangiomas, malformations grow commensurately with the patient and do not involute. Growth is driven by progressive hemodynamic distention of aberrant channels rather than cellular proliferation. Recurrence following incomplete excision is common and results from the rerouting of blood flow into previously quiescent collateral channels.

Malformations are hemodynamically stratified into low-flow and high-flow lesions:

Low-Flow Malformations (Venous, Capillary, Lymphatic)

Comprising 90% of vascular malformations, low-flow lesions consist of large dysplastic channels devoid of normal intervening parenchyma.

Venous Malformations: These present as bluish, compressible masses that engorge with dependency and decompress with elevation. Chronic stasis frequently leads to localized thrombosis, presenting as acute pain and palpable phleboliths.

Capillary Malformations: Commonly known as "port-wine stains" (nevus flammeus), these present as flat, dark red to purple macules. Histologically, they feature dilated capillaries and postcapillary venules in the superficial dermis.

Lymphatic Malformations: These lesions enlarge secondary to fluid sequestration, inadequate lymphatic drainage, or recurrent cellulitis. They can cause massive soft-tissue distortion, joint contractures, and reactive bone hypertrophy.

High-Flow Malformations (Arteriovenous Malformations)

High-flow malformations contain direct arteriovenous shunts (nidus) bypassing the capillary bed. They exhibit a bimodal clinical presentation: recognized at birth (40%) or during adolescence (34%). They are staged by their clinical behavior:
* Type A: Localized AVFs, aneurysms, or ectasias.
* Type B: Localized arteriovenous anomalies with micro/macrofistulas confined to a single limb or digit.
* Type C: Diffuse lesions involving multiple tissue planes. These are highly morbid, causing vascular steal, distal ischemia, ulceration, and potentially high-output congestive heart failure.

Acquired Vascular Lesions

True Aneurysms

True aneurysms involve all three layers of the vessel wall (intima, media, adventitia). In the hand, they account for 6% of upper extremity tumors. The classic etiology is Hypothenar Hammer Syndrome, resulting from repetitive blunt trauma to the ulnar artery against the hook of the hamate, leading to medial degeneration and fusiform dilation. Systemic etiologies include atherosclerosis, Kawasaki disease, Buerger disease, and connective tissue disorders.

Pseudoaneurysms

Representing 83% of hand aneurysms, pseudoaneurysms lack a complete vessel wall; the hematoma is contained only by surrounding adventitia and soft tissue. They typically arise weeks to months following penetrating trauma (e.g., knife wound, iatrogenic puncture). They present as a pulsatile mass, often with an audible bruit.

Acquired Arteriovenous Fistulas

Traumatic AVFs occur when simultaneous penetrating injury to an adjacent artery and vein creates a direct, aberrant communication.

Glomus Tumors

Glomus tumors are benign hamartomas of the glomus body. Up to 90% are solitary and located in the subungual region. They are typically minute (less than 1 cm) and encapsulated. Multiple glomus tumors (glomangiomas) are less common, nonencapsulated, and often inherited in an autosomal dominant pattern.

Patients present with a classic diagnostic triad:
1. Paroxysmal, lancinating pain.
2. Pinpoint point tenderness.
3. Severe cold hypersensitivity.

Malignant Vascular Tumors

Malignant vascular tumors of the hand are exceedingly rare but carry a grave prognosis. These include hemangioendotheliomas, hemangiopericytomas, and angiosarcomas. They present as rapidly enlarging, invasive masses, often with overlying skin changes or ulceration.

Clinical Evaluation and Physical Examination

A meticulous history and physical examination dictate the diagnostic algorithm. The surgeon must establish the chronicity of the lesion: presence at birth suggests a malformation, rapid postnatal growth suggests an infantile hemangioma, and late onset suggests an acquired or malignant process.

Physical Examination Pearls:
* Low-Flow Malformations: Assess for bluish discoloration, compressibility, and engorgement with dependency. Palpate for hard, spherical nodules indicative of phleboliths. Check for syndromic associations (e.g., Klippel-Trenaunay, Maffucci syndrome).
* High-Flow Malformations: Palpate for increased local temperature, thrills, and auscultate for bruits. Perform the Nicoladoni-Branham sign: occlusion of the proximal feeding artery results in reflex bradycardia. Assess for signs of distal ischemia or vascular steal.
* Glomus Tumors:
* Love Pin Test: Use a paperclip or pinhead to localize pinpoint tenderness over the nail plate.
* Hildreth Test: Exsanguinate the digit and apply a proximal tourniquet. If the pain elicited by the Love test is acutely relieved, the test is positive (highly specific for glomus tumor).
* Cold Sensitivity Test: Application of an ice cube or cold spray elicits severe, disproportionate pain.
* Vascular Integrity: A comprehensive Allen test is mandatory to evaluate the patency and dominance of the superficial palmar arch prior to any surgical intervention.

Imaging and Diagnostic Modalities

While clinical examination is paramount, advanced imaging is critical for staging, preoperative planning, and determining hemodynamic flow characteristics.

• Plain Radiography: Useful for identifying phleboliths (pathognomonic for venous malformations), reactive cortical thickening, or osseous destruction (seen in aggressive malignancies or massive AVMs).
• Doppler Ultrasound: Highly effective, non-invasive first-line modality. It differentiates high-flow (biphasic/triphasic arterial waveforms) from low-flow (monophasic, low-velocity ~0.22 kHz) anomalies and identifies intralesional thrombi.
• Magnetic Resonance Imaging (MRI/MRA): The gold standard for defining anatomic extent and soft-tissue involvement. Hemangiomas exhibit well-circumscribed borders, intermediate T1 signal, intensely bright T2 signal, and homogenous gadolinium enhancement. Malformations may show "serpentine" flow voids. MRA maps the feeding and draining vasculature without the need for nephrotoxic contrast.
• Angiography: While largely supplanted by MRA for diagnosis, digital subtraction angiography (DSA) remains the definitive modality for real-time hemodynamic evaluation and therapeutic intervention (e.g., preoperative embolization).

Nonoperative Management Strategies

Conservative management is dictated by the specific pathology, anatomic location, and functional impairment.

• Observation: The mainstay for infantile hemangiomas, as up to 90% undergo complete spontaneous involution by age 9.
• Pharmacotherapy: For life- or limb-threatening hemangiomas, systemic therapies including high-dose corticosteroids, interferon alpha-2a/2b, or (more recently) oral propranolol are utilized.
• Compression Therapy: Custom-fitted, graduated compression garments are vital for managing symptomatic venous and lymphatic malformations, mitigating edema, preventing thrombosis, and controlling pain. Low-dose aspirin may be added to prevent consumptive coagulopathy.
• Laser Therapy: Pulsed dye laser (585-nm) specifically targets hemoglobin and is highly effective for superficial capillary malformations (port-wine stains) and the superficial components of hemangiomas.
• Sclerotherapy: The primary treatment for symptomatic venous and lymphatic malformations. Agents such as 1% sodium tetradecyl sulfate (for small lesions) or absolute ethanol (for large, deep lesions) induce endothelial destruction and fibrosis.
• Endovascular Embolization: Utilized primarily for high-flow AVMs. Feeding vessels are selectively catheterized and occluded using polyvinyl alcohol (PVA) particles, coils, or tissue adhesives (N-butyl cyanoacrylate). Embolization is rarely curative alone and is typically performed 24 to 48 hours prior to surgical resection to minimize intraoperative hemorrhage.

Surgical Management and Operative Techniques

Surgical intervention is indicated for intractable pain, functional impairment, recurrent hemorrhage, refractory ulceration, malignant transformation, or severe cosmetic deformity.

Preoperative Planning and Patient Positioning

Thorough preoperative mapping via MRI and MRA is mandatory. The surgeon must confirm the patency of the palmar arch (Allen test); if a dominant radial or ulnar artery requires resection, the surgeon must be prepared for immediate autogenous vein grafting.

Positioning and Tourniquet Use:
A proximal pneumatic arm tourniquet is applied. Crucially, the upper extremity should NOT be tightly exsanguinated with an Esmarch bandage when resecting vascular malformations or hemangiomas. Forceful exsanguination empties the anomalous vascular channels, rendering the margins of the lesion indistinguishable from surrounding normal tissue. Instead, the arm is elevated for 2-3 minutes prior to tourniquet inflation to allow gravity drainage, ensuring the lesion remains partially engorged and visually distinct.

Surgical Approaches and Principles of Excision

The surgical approach is dictated by the lesion's anatomic location. Staged resections are frequently required for diffuse venous, lymphatic, or Type B/C high-flow malformations.

Key Surgical Principles for Vascular Anomalies:
1. Meticulous hemostasis utilizing bipolar electrocautery and strict tourniquet control.
2. Dissection must proceed systematically within defined anatomic planes.
3. Identification and preservation of all vital neurovascular structures (utilizing loupe magnification).
4. Proximal and distal control of all feeding and draining vessels prior to division.
5. If distal ischemia is noted upon temporary clamping of a major vessel, bypass grafting must be performed.

Transungual Excision for Glomus Tumors

The transungual approach provides direct, optimal exposure for subungual glomus tumors.

Technique:
1. Perform a digital block and apply a digital or proximal tourniquet.
2. Carefully elevate and remove the nail plate using a Freer elevator, preserving the plate for postoperative splinting.
3. Identify the tumor, which typically appears as a distinct bluish nodule visible through the nail bed.
4. Make a longitudinal incision through the sterile matrix directly over the tumor.
5. Gently spread the matrix to expose the encapsulated tumor.
6. Perform a meticulous marginal excision. Glomus tumors typically shell out easily. Inspect the cavity for satellite lesions, which are a primary cause of recurrence.
7. Repair the nail bed meticulously using 6-0 absorbable sutures (e.g., chromic gut or Vicryl rapide) to prevent postoperative nail dystrophy.
8. Replace the native nail plate (or a synthetic substitute) into the eponychial fold to stent the matrix and prevent synechiae.

![Image](/media/upload/678996c8-17b7-44c7-81d1-bb

Clinical & Radiographic Imaging